Vestipitant and Vofopitant 2 Day PSG Study for Insomnia
Phase of Trial: Phase II
Latest Information Update: 13 Jul 2017
At a glance
- Drugs Vestipitant (Primary) ; Vofopitant (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 20 May 2009 Actual end date (May 2008) added as reported by ClinicalTrials.gov.
- 27 Oct 2008 Planned end date changed from Sep 2008 to May 2008 as reported by Clinicaltrials.gov.
- 27 Oct 2008 Trial phase changed from I to II as reported by ClinicalTrials.gov.